Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR009057)
Formula
SVG example
Unclear
Reactant Bevacizumab + Trastuzumab Product 3-Keto-lithocholic acid(3KLA)
Reactant Info Product Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR009063 Bevacizumab + Trastuzumab Glyco-LCA (GLCA) Unclear - Unclear Bevacizumab + Trastuzumab [1]
MR009064 Bevacizumab + Trastuzumab Tauro-LCA (TLCA) Unclear - Unclear Bevacizumab + Trastuzumab [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR009058 3-Keto-lithocholic acid(3KLA) Isolithocholic acid Unclear - Unclear Bevacizumab + Trastuzumab [2]
References
1 Inhibition of Human Sulfotransferase 2A1-Catalyzed Sulfonation of Lithocholic Acid, Glycolithocholic Acid, and Taurolithocholic Acid by Selective Estrogen Receptor Modulators and Various Analogs and Metabolites
2 The metabolism of lithocholic acid and lithocholic acid-3-alpha-sulfate by human fecal bacteria

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.